Morgan Stanley’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.11M | Sell |
1,299,775
-67,344
| -5% | -$110K | ﹤0.01% | 4733 |
|
|
2025
Q4 | $2.76M | Sell |
1,367,119
-1,534,083
| -53% | -$3.59M | ﹤0.01% | 4588 |
|
|
2025
Q3 | $6.18M | Sell |
2,901,202
-182,288
| -6% | -$398K | ﹤0.01% | 3974 |
|
|
2025
Q2 | $6.29M | Buy |
3,083,490
+1,699,997
| +123% | +$2.77M | ﹤0.01% | 3860 |
|
|
2025
Q1 | $1.84M | Buy |
1,383,493
+897,508
| +185% | +$1.91M | ﹤0.01% | 4657 |
|
|
2024
Q4 | $1.29M | Buy |
485,985
+211,535
| +77% | +$672K | ﹤0.01% | 4957 |
|
|
2024
Q3 | $499K | Buy |
274,450
+196,508
| +252% | +$369K | ﹤0.01% | 5409 |
|
|
2024
Q2 | $129K | Buy |
77,942
+10,351
| +15% | +$20.1K | ﹤0.01% | 5869 |
|
|
2024
Q1 | $155K | Sell |
67,591
-159,831
| -70% | -$342K | ﹤0.01% | 5817 |
|
|
2023
Q4 | $450K | Sell |
227,422
-115,536
| -34% | -$178K | ﹤0.01% | 5661 |
|
|
2023
Q3 | $446K | Sell |
342,958
-152,558
| -31% | -$240K | ﹤0.01% | 5222 |
|
|
2023
Q2 | $803K | Sell |
495,516
-153,342
| -24% | -$299K | ﹤0.01% | 4957 |
|
|
2023
Q1 | $1.38M | Buy |
648,858
+270,208
| +71% | +$826K | ﹤0.01% | 4679 |
|
|
2022
Q4 | $1.4M | Sell |
378,650
-99,063
| -21% | -$130K | ﹤0.01% | 4678 |
|
|
2022
Q3 | $355K | Buy |
477,713
+78,918
| +20% | +$63.4K | ﹤0.01% | 5444 |
|
|
2022
Q2 | $311K | Buy |
398,795
+196,891
| +98% | +$147K | ﹤0.01% | 5665 |
|
|
2022
Q1 | $183K | Buy |
201,904
+165,283
| +451% | +$554K | ﹤0.01% | 5977 |
|
|
2021
Q4 | $293K | Sell |
36,621
-74,449
| -67% | -$567K | ﹤0.01% | 5860 |
|
|
2021
Q3 | $930K | Sell |
111,070
-273,802
| -71% | -$1.79M | ﹤0.01% | 5093 |
|
|
2021
Q2 | $2.59M | Sell |
384,872
-95,691
| -20% | -$617K | ﹤0.01% | 4432 |
|
|
2021
Q1 | $3.18M | Sell |
480,563
-533,512
| -53% | -$2.73M | ﹤0.01% | 3873 |
|
|
2020
Q4 | $4.26M | Buy |
1,014,075
+798,966
| +371% | +$3.37M | ﹤0.01% | 3430 |
|
|
2020
Q3 | $1.03M | Sell |
215,109
-174,769
| -45% | -$914K | ﹤0.01% | 4199 |
|
|
2020
Q2 | $2.37M | Buy |
389,878
+186,396
| +92% | +$1.01M | ﹤0.01% | 3438 |
|
|
2020
Q1 | $1.12M | Buy |
203,482
+201,816
| +12,114% | +$1.55M | ﹤0.01% | 3871 |
|
|
2019
Q4 | $17K | Sell |
1,666
-705
| -30% | -$5.49K | ﹤0.01% | 6141 |
|
|
2019
Q3 | $14K | Buy |
2,371
+367
| +18% | +$2.93K | ﹤0.01% | 6112 |
|
|
2019
Q2 | $18K | Sell |
2,004
-76,453
| -97% | -$902K | ﹤0.01% | 5971 |
|
|
2019
Q1 | $1.09M | Sell |
78,457
-235,538
| -75% | -$3.52M | ﹤0.01% | 4049 |
|
|
2018
Q4 | $4.96M | Sell |
313,995
-92,289
| -23% | -$1.69M | ﹤0.01% | 2917 |
|
|
2018
Q3 | $7.86M | Buy |
406,284
+115,709
| +40% | +$1.23M | ﹤0.01% | 2675 |
|
|
2018
Q2 | $2.12M | Buy |
290,575
+60,575
| +26% | +$305K | ﹤0.01% | 4029 |
|
|
2018
Q1 | $707K | Buy |
230,000
+52,400
| +30% | +$169K | ﹤0.01% | 4789 |
|
|
2017
Q4 | $573K | Buy |
177,600
+76,300
| +75% | +$274K | ﹤0.01% | 4894 |
|
|
2017
Q3 | $491K | Buy |
101,300
+39,428
| +64% | +$205K | ﹤0.01% | 4890 |
|
|
2017
Q2 | $322K | Buy |
61,872
+13,319
| +27% | +$66.2K | ﹤0.01% | 5065 |
|
|
2017
Q1 | $243K | Sell |
48,553
-3,458
| -7% | -$15.2K | ﹤0.01% | 5224 |
|
|
2016
Q4 | $255K | Buy |
52,011
+18,211
| +54% | +$93.8K | ﹤0.01% | 5257 |
|
|
2016
Q3 | $226K | Buy |
33,800
+3,500
| +12% | +$19.3K | ﹤0.01% | 4956 |
|
|
2016
Q2 | $147K | Buy |
30,300
+29,300
| +2,930% | +$151K | ﹤0.01% | 5072 |
|
|
2016
Q1 | $5K | Buy |
+1,000
| New | +$5.08K | ﹤0.01% | 6284 |
|
|
2015
Q4 | – | Sell |
-33,516
| Closed | -$488K | – | 6756 |
|
|
2015
Q3 | $488K | Sell |
33,516
-3,955
| -11% | -$66.2K | ﹤0.01% | 4624 |
|
|
2015
Q2 | $625K | Sell |
37,471
-8,899
| -19% | -$168K | ﹤0.01% | 4547 |
|
|
2015
Q1 | $1.01M | Buy |
46,370
+4,799
| +12% | +$99.1K | ﹤0.01% | 4120 |
|
|
2014
Q4 | $901K | Buy |
41,571
+25,726
| +162% | +$390K | ﹤0.01% | 4231 |
|
|
2014
Q3 | $272K | Buy |
+15,845
| New | +$254K | ﹤0.01% | 4969 |
|
Other funds holding PRQR
PFM
AAA
SCM
DCM
KCM
IC
PIM
